Skip to main content

Table 3 Pre-therapy and post-therapy findings on SRS and SGS in salivary glands

From: Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren’s syndrome treated with Infliximab: a pilot study

 

Pre-therapy scan

Post-therapy scan

 

SRS

SGS

 

SRS

SGS

Patient

n

Global score

Functional score

n

Global score

Functional score

1

4

6

7.5

3

3

7.5

3

2

2

5

5

2

2.5

4

2

2

4.5

2

2

4.4

5

1

1

5.4

1

1

6.3

6

0

0

6.2

0

0

6.3

7

0

0

5.2

0

0

6.1

8

2

4

5.7

2

2

6.5

9

0

0

6.5

0

0

6.7

12

0

0

7.6

0

0

7.4

14

0

0

6.2

0

0

6.4

18

2

4

5.8

2

3

5.9

Mean

1.18

1.73

5.96

1.09*

1.18*

6.23*

±SD

1.33

2.1

0.97

1.14

1.25

0–91

  1. Table shows values of the number of positive joints (n), of the global score and of the functional score in the salivary glands of the 11 patients that performed somatostatin receptor scintigraphy (SRS) before and after treatment with infliximab
  2. *p = n.s. vs pre-therapy values